Diehl LF - Search Results

1

(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

Mylam KJ, Kostakoglu L, Hutchings M, Coleman M, Lamonica D, Czuczman MS, Diehl LF, Nielsen AL, Jensen P, Loft A, Hendel HW, Iyer V, Leppä S, Jyrkkiö S, Holte H, Eriksson M, Gillstrøm D, Hansen PB, Seppänen M, Hjorthaug K, Brown Pde N, Pedersen LM. Mylam KJ, et al. Among authors: diehl lf. Leuk Lymphoma. 2015 Jul;56(7):2005-12. doi: 10.3109/10428194.2014.975800. Epub 2014 Nov 20. Leuk Lymphoma. 2015. PMID: 25330442

2

In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma.

Hutchings M, Kostakoglu L, Zaucha JM, Malkowski B, Biggi A, Danielewicz I, Loft A, Specht L, Lamonica D, Czuczman MS, Nanni C, Zinzani PL, Diehl L, Stern R, Coleman M. Hutchings M, et al. J Clin Oncol. 2014 Sep 1;32(25):2705-11. doi: 10.1200/JCO.2013.53.2838. Epub 2014 Jul 28. J Clin Oncol. 2014. PMID: 25071108

3

Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma.

Brander D, Rizzieri D, Gockerman J, Diehl L, Shea TC, Decastro C, Moore JO, Beaven A. Brander D, et al. Leuk Lymphoma. 2013 Dec;54(12):2627-30. doi: 10.3109/10428194.2013.784969. Epub 2013 Apr 19. Leuk Lymphoma. 2013. PMID: 23488610 Free PMC article. Clinical Trial.

4

Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Islam P, Rizzieri D, Lin C, de Castro C, Diehl L, Li Z, Moore J, Morris T, Beaven A. Islam P, et al. Cancer Invest. 2021 Nov;39(10):871-879. doi: 10.1080/07357907.2021.1983584. Epub 2021 Oct 13. Cancer Invest. 2021. PMID: 34643126 Clinical Trial.

5

Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.

Heyman B, Rizzieri D, Adams DJ, De Castro C, Diehl L, Li Z, Moore J, Beaven A. Heyman B, et al. Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):679-686. doi: 10.1016/j.clml.2018.07.285. Epub 2018 Jul 29. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30166257 Clinical Trial.

6

The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.

Dorth JA, Chino JP, Prosnitz LR, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. Dorth JA, et al. Among authors: diehl lf. Ann Oncol. 2011 Feb;22(2):405-10. doi: 10.1093/annonc/mdq389. Epub 2010 Jul 30. Ann Oncol. 2011. PMID: 20675560 Free article.

7

Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.

Lanasa MC, Davis PH, Datto M, Li Z, Gockerman JP, Moore JO, DeCastro CM, Friedman DR, Diehl LF, Rehder C, Cook H, Daugherty FJ, Matta KM, Weinberg JB, Rizzieri D. Lanasa MC, et al. Among authors: diehl lf. Leuk Lymphoma. 2012 Feb;53(2):218-24. doi: 10.3109/10428194.2011.610012. Epub 2011 Sep 23. Leuk Lymphoma. 2012. PMID: 21827374

8

Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging.

Dorth JA, Prosnitz LR, Broadwater G, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. Dorth JA, et al. Among authors: diehl lf. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):762-7. doi: 10.1016/j.ijrobp.2011.12.067. Epub 2012 Mar 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 22420972

9

Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma.

Kelsey CR, Broadwater G, James O, Chino J, Diehl L, Beaven AW, Chang C, Koontz BF, Prosnitz LR. Kelsey CR, et al. Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):96-101. doi: 10.1016/j.ijrobp.2019.02.055. Epub 2019 Mar 8. Int J Radiat Oncol Biol Phys. 2019. PMID: 30858144 Free PMC article. Clinical Trial.

10

Radiation therapy in the management of diffuse large B-cell lymphoma: still relevant?

Kelsey CR, Beaven AW, Diehl LF, Prosnitz LR. Kelsey CR, et al. Among authors: diehl lf. Oncology (Williston Park). 2010 Nov 30;24(13):1204-12. Oncology (Williston Park). 2010. PMID: 21192559 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page